XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.

U.S. Avidity Biosciences, Broadcom, Cara Therapeutics



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-Avidity Biosciences, Broadcom, Cara Therapeutics</title></head><body>

June 13 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avidity Biosciences, Broadcom and Cara Therapeutics, on Thursday.


HIGHLIGHTS

* Avidity Biosciences Inc RNA.O: Leerink Partners raises target price to $56 from $38

* Broadcom Inc AVGO.O: TD Cowen raises target price to $1,750 from $1,500

* Cara Therapeutics Inc CARA.O: Canaccord Genuity cuts to hold from buy

* Labcorp LH.N: Baird raises target price to $258 from $256

* Meritage Homes Corp MTH.N: Evercore ISI raises target price to $219 from $217

Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.

* 3M Co MMM.N: Wolfe Research raises to outperform from peer perform

* Albemarle Corp ALB.N: UBS cuts target price to $124 from $132

* Allegro Microsystems Inc ALGM.O: TD Cowen raises target price to $35 from $32

* Amphenol APH.N: Evercore ISI adjusts PT to $75 from $150 to reflect 2-for-1 stock split

* Amphenol APH.N: Stifel adjusts PT to $66 from $112 to reflect 2-for-1 stock split

* Ares Management Corp ARES.N: Deutsche Bank resumes coverage with hold rating; PT $132

* Atlassian Corp TEAM.O: Citigroup adds stock to its north american focus list

* Avidity Biosciences Inc RNA.O: BofA Global Research raises PT to $45 from $40

* Avidity Biosciences Inc RNA.O: Evercore ISI raises target price to $45 from $40

* Avidity Biosciences Inc RNA.O: Leerink Partners raises target price to $56 from $38

* Avidity Biosciences Inc RNA.O: Needham raises target price to $46 from $35

* Avidity Biosciences Inc RNA.O: Raymond James raises target price to $90 from $66

* Barnes Group Inc B.N: D.A. Davidson raises target price to $48 from $45

* Boeing BA.N: BofA Global Research raises price objective to $200 from $180

* Broadcom Inc AVGO.O: Barclays raises target price to $2000 from $1500

* Broadcom Inc AVGO.O: Benchmark raises target price to $2,100 from $1,750

* Broadcom Inc AVGO.O: Bernstein raises target price to $1,950 from $1,600

* Broadcom Inc AVGO.O: BofA Global Research raises price objective to $2000 from $1680

* Broadcom Inc AVGO.O: Evercore ISI raises target price to $2010 from $1620

* Broadcom Inc AVGO.O: Jefferies raises target price to $2050 from $1550

* Broadcom Inc AVGO.O: JP Morgan raises target price to $2000 from $1700

* Broadcom Inc AVGO.O: Mizuho raises target price to $1,900 from $1,625

* Broadcom Inc AVGO.O: Morgan Stanley raises target price to $1,765 from $1,658

* Broadcom Inc AVGO.O: Oppenheimer raises target price to $2000 from $1500

* Broadcom Inc AVGO.O: Rosenblatt Securities raises target price to $1,650 from $1,500

* Broadcom Inc AVGO.O: Susquehanna raises target price to $2,000 from $1,650

* Broadcom Inc AVGO.O: TD Cowen raises target price to $1,750 from $1,500

* Broadcom Inc AVGO.O: Truist Securities raises target price to $2,045 from $1,566

* Broadcom Inc AVGO.O: UBS raises target price to $1,735 from $1,610

* Broadcom Inc AVGO.O: Wells Fargo raises target price to $1,700 from $1,430

* Cara Therapeutics Inc CARA.O: Canaccord Genuity cuts to hold from buy

* Cara Therapeutics Inc CARA.O: Needham cuts to hold from buy

* Cara Therapeutics Inc CARA.O: Stifel cuts to hold from buy; cuts PT to $1 from $6

* Caretrust REIT Inc CTRE.N: BMO raises target price to $29 from $27

* Caseys General Stores Inc CASY.O: Benchmark raises target price to $410

* Caseys General Stores Inc CASY.O: BMO raises target price to $400 from $305

* Caseys General Stores Inc CASY.O: Deutsche Bank raises target price to $420 from $375

* Caseys General Stores Inc CASY.O: Jefferies raises target price to $445 from $342

* Caseys General Stores Inc CASY.O: Wells Fargo raises target price to $415 from $340

* Cava Group Inc CAVA.N: TD Cowen raises target price to $95 from $90

* Celsius Holdings Inc CELH.O: Jefferies cuts target price to $98 from $104

* Celsius Holdings Inc CELH.O: TD Cowen cuts target price to $85 from $95

* Charles River Laboratories International Inc CRL.N: Baird raises PT to $271 from $270

* Chipotle Mexican Grill Inc CMG.N: Goldman Sachs initiates coverage with buy rating

* Chipotle Mexican Grill Inc CMG.N: Goldman Sachs initiates coverage with PT $3,730

* Chipotle Mexican Grill Inc CMG.N: TD Cowen raises target price to $3,600 from $3,500

* Civitas Resources Inc CIVI.N: TD Cowen initiates coverage with buy rating; PT $90

* Clean Harbors Inc CLH.N: Oppenheimer raises target price to $245 from $218

* Coca-Cola Co KO.N: Citigroup adds stock to its north american focus list

* Corning Inc GLW.N: Jefferies raises target price to $33.5 from $30

* Corning Inc GLW.N: Morgan Stanley cuts to equal-weight from overweight

* Corning Inc GLW.N: Morgan Stanley raises target price to $38 from $35

* Darden Restaurants Inc DRI.N: BofA Global Research cuts PT to $180 from $194

* Darden Restaurants Inc DRI.N: Evercore ISI cuts target price to $165 from $170

* Darden Restaurants Inc DRI.N: TD Cowen cuts target price to $170 from $190

* Darling Ingredients Inc DAR.N: TD Cowen cuts target price to $45 from $51

* Dave & Buster'S Entertainment Inc PLAY.O: BMO cuts target price to $65 from $75

* Dave & Buster'S Entertainment Inc PLAY.O: Jefferies cuts target price to $75 from $80

* Dave & Buster'S Entertainment Inc PLAY.O: Truist Securities cuts PT to $64 from $67

* Domino's Pizza Inc DPZ.N: Goldman Sachs initiates coverage with buy rating; target price $612

* Domino's Pizza Inc DPZ.N: TD Cowen raises target price to $610 from $580

* Dutch Bros Inc BROS.N: TD Cowen raises target price to $50 from $46

* Enovis Corp ENOV.N: JP Morgan initiates coverage with neutral rating; price target $53

* Evergy Inc EVRG.O: Citigroup adds stock to its north american focus list

* First Horizon Corp FHN.N: Citigroup removes stock from its north american focus list

* First Watch Restaurant Group Inc FWRG.O: TD Cowen cuts target price to $21 from $25

* FMC Corp FMC.N: UBS cuts target price to $81 from $86

* Fox Factory Holding Corp FOXF.O: Truist Securities raises PT to $55 from $50

* Ftai Aviation Ltd FTAI.O: Morgan Stanley raises target price to $105 from $85

* General Mills Inc GIS.N: Jefferies cuts target price to $69 from $71

* Goodyear Tire & Rubber Co GT.O: Morgan Stanley initiates coverage with equal weight rating

* Goodyear Tire & Rubber Co GT.O: Morgan Stanley initiates coverage with target price $14

* Hertz Global HTZ.O: BofA Global Research cuts price objective to $2.5 from $3

* Hims & Hers Health Inc HIMS.N: BofA Global Research raises PT to $26 from $22

* Huntington Bancshares Inc HBAN.O: UBS cuts target price to $15 from $16

* Iqvia Holdings Inc IQV.N: Baird cuts target price to $241 from $245

* Jack In the Box Inc JACK.O: Goldman Sachs initiates coverage with sell rating; PT $55

* Kimberly-Clark Corp KMB.N: BofA Global Research raises to buy from underperform

* Kimberly-Clark Corp KMB.N: BofA Global Research ups price objective to $160 from $115

* Kontoor Brands Inc KTB.N: Wells Fargo raises target price to $80 from $76

* Kura Oncology Inc KURA.O: BofA Global Research raises price objective to $35 from $33

* Labcorp LH.N: Baird raises target price to $258 from $256

* Lear Corp LEA.N: UBS cuts target price to $136 from $142

* Lexeo Therapeutics Inc LXEO.O: Baird initiates coverage with outperform rating; PT $28

* Matador Resources Co MTDR.N: Raymond James raises target price to $79 from $77

* Matador Resources Co MTDR.N: Truist Securities raises target price to $91 from $87

* McDonald's MCD.N: Goldman Sachs initiates coverage with neutral rating; target price $288

* Medpace Holdings Inc MEDP.O: Baird raises target price to $456 from $454

* Meritage Homes Corp MTH.N: Evercore ISI raises target price to $219 from $217

* Monolithic Power Systems Inc MPWR.O: Oppenheimer raises target price to $900 from $750

* Monster Beverage Corp MNST.O: Jefferies cuts target price to $61 from $68

* National Health Investors Inc NHI.N: BMO raises target price to $74 from $67

* National Vision Holdings Inc EYE.O: BofA Global Research cuts PT to $16 from $17

* Nextera Energy Inc NEE.N: Barclays cuts target price to $73 from $74

* Nike Inc NKE.N: Deutsche Bank resumes coverage with buy rating; price target $115

* Omega Healthcare Investors Inc OHI.N: BMO raises target price to $37 from $35

* Oxford Industries Inc OXM.N: Citigroup cuts target price to $92 from $94

* Oxford Industries Inc OXM.N: UBS cuts target price to $101 from $104

* PAR Technology Corp PAR.N: Stephens raises target price to $60 from $46

* PAR Technology Corp PAR.N: Stephens raises to overweight from equal-weight

* PG&E Corp PCG.N: RBC raises target price to $22 from $21

* Regency Centers Corp REG.O: Deutsche Bank cuts target price to $70 from $74

* Roblox Corp RBLX.N: Wells Fargo raises target price to $41 from $37

* Royal Caribbean Group RCL.N: Citigroup adds stock to its north american focus list

* Rubrik Inc RBRK.N: Citigroup raises target price to $47 from $46

* Saia Inc SAIA.O: BMO raises target price to $500 from $490

* Scholar Rock Holding Corp SRRK.O: BMO raises target price to $31 from $29

* Shake Shack Inc SHAK.N: Goldman Sachs initiates coverage with buy rating; target price $110

* Simulations Plus Inc SLP.O: Craig-Hallum raises target price to $56 from $51

* Simulations Plus Inc SLP.O: Oppenheimer raises target price to $65 from $55

* Skechers USA Inc SKX.N: Deutsche Bank resumes coverage with buy rating; PT $82

* Skechers USA Inc SKX.N: Monness Crespi Hardt raises target price to $85 from $72

* SL Green Realty Corp SLG.N: Citigroup raises target price to $37 from $31

* Spruce Biosciences SPRB.O: Oppenheimer cuts target price to $3 from $4

* Starbucks SBUX.O: Goldman Sachs initiates coverage with buy rating; target price $100

* Sweetgreen Inc SG.N: Goldman Sachs initiates coverage with buy rating; target price $39

* Sweetgreen Inc SG.N: TD Cowen raises target price to $31 from $26

* Syndax Pharmaceuticals Inc SNDX.O: BofA Global Research raises PT to $31 from $29

* Torrid Holdings Inc CURV.N: Jefferies raises target price to $7 from $4.8

* Torrid Holdings Inc CURV.N: Telsey Advisory Group raises target price to $8 from $6

* Twist Bioscience Corp TWST.O: TD Cowen raises target price to $65 from $55

* Ventas Inc VTR.N: BMO raises target price to $57 from $53

* Viavi Solutions Inc VIAV.O: Morgan Stanley cuts target price to $9.00 from $10.00

* Vicarious Surgical Inc RBOT.N: Morgan Stanley raises target price to $18.00 from $0.60

* Walmart WMT.N: Citigroup removes stock from its north american focus list

* Welltower Inc WELL.N: BMO raises target price to $115 from $110

* Wendy's Co WEN.O: Goldman Sachs initiates coverage with sell rating; target price $16

* Williams Companies Inc WMB.N: RBC raises target price to $44 from $40

* Wingstop Inc WING.O: Goldman Sachs initiates coverage with neutral rating; PT $407

* Wingstop Inc WING.O: TD Cowen raises target price to $450 from $430

* Yum Brands YUM.N: Goldman Sachs initiates coverage with neutral rating; PT $150


(Compiled by Bengaluru Newsroom)

</body></html>

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.